Business Details
50+ Years
experience
Trusted Global Healthcare Solutions
Founded in 1912, Fresenius has evolved from a local pharmacy into a global healthcare leader, operating in over 100 countries with 176,000 employees. Our expertise spans critical and chronic care, offering innovative pharmaceuticals, clinical nutrition, and hospital services to improve patient outcomes. With a legacy of 113 years in healthcare innovation, we combine deep industry knowledge with cutting-edge technology to address complex medical challenges.Our commitment to quality is reflected in rigorous compliance standards and partnerships that enhance accessibility to life-saving treatments. As a trusted partner in healthcare systems worldwide, we prioritize patient-centric solutions, ethical practices, and sustainable growth to deliver long-term value for stakeholders.
Services
Pharmaceuticals
Clinical Nutrition
Hospital Services
Biosimilars
Medical Technology
Details
- Year established: 1912
Highlights and features
- We have over 110 years of experience in pharmaceutical and medical innovation.
- Our global network operates in 100+ countries with 176,000 dedicated healthcare professionals.
- We combine cutting-edge biopharmaceuticals with advanced medical technology for holistic care.
- Our commitment to sustainability ensures ethical and environmentally responsible practices.
- We lead in biosimilars and personalized therapies for chronic and critical conditions.
Services
Pharmaceuticals
Fresenius develops and distributes essential pharmaceuticals, including intravenous generics and biosimilars, for treating chronic and critical conditions. Our products ensure reliable access to high-quality treatments across global markets. With a focus on affordability and innovation, we address unmet medical needs in oncology, immunology, and rare diseases.
Clinical Nutrition
We provide enteral and parenteral nutrition solutions for patients with specialized dietary requirements. Our Fresubin brand offers comprehensive products to support recovery and long-term health. Backed by clinical research, these solutions cater to hospital and homecare settings worldwide.
Biosimilars
Fresenius Kabi leads in biosimilar development, offering cost-effective alternatives to biologic drugs for cancer and autoimmune diseases. Our pipeline includes denosumab, ustekinumab, and vedolizumab biosimilars. These therapies expand patient access to advanced treatments while maintaining rigorous quality standards.
Hospital Services
Fresenius Helios operates 140 hospitals and outpatient centers in Germany and Spain, providing high-quality acute and specialized care. Our facilities integrate advanced diagnostics, robotic surgery, and personalized treatment plans to enhance patient outcomes and operational efficiency.
Medical Technology
We manufacture dialysis machines, infusion systems, and cell therapy technologies that support critical care workflows. Innovations like the Lovo and Cue cell processing systems enable decentralized CAR-T therapy, improving treatment accessibility and efficiency for oncology patients.
People
Michael Sen
CEO
Michael Sen leads Fresenius with over 25 years of healthcare executive experience, driving the #FutureFresenius strategy to strengthen core businesses and innovation platforms.
Anke Schmidt
Head of Corporate Communications
Anke Schmidt oversees global communications, leveraging 20+ years in corporate strategy and stakeholder engagement to enhance Fresenius' brand and sustainability initiatives.
Dr. Sang-Jin Pak
President Biopharma
Dr. Pak directs Fresenius Kabi's biopharma division, advancing biosimilar pipelines and partnerships to expand access to high-quality therapies for chronic diseases.
Ralf Kuhlen
Chief Medical Officer
Ralf Kuhlen drives medical strategy, focusing on evidence-based solutions and policy advocacy to improve global healthcare delivery and patient outcomes.
Marc-Alexander Mahl
President Pharma
Marc-Alexander Mahl leads pharmaceutical operations, emphasizing innovation in drug development and sustainable manufacturing practices across Fresenius' global supply chain.
Questions
What healthcare solutions does Fresenius provide?
Fresenius offers pharmaceuticals, clinical nutrition, medical technology, and hospital services for critically and chronically ill patients.
Where does Fresenius operate globally?
Fresenius operates in over 100 countries with a focus on Europe, North America, and Latin America.
What are Fresenius' key innovations?
We lead in biosimilars, personalized therapies, and advanced medical technologies for chronic disease management.
How does Fresenius ensure product quality?
Our rigorous compliance standards and ISO-certified manufacturing processes guarantee high-quality healthcare products.
What sustainability initiatives does Fresenius prioritize?
We focus on reducing carbon emissions, sustainable supply chains, and improving healthcare accessibility worldwide.
Videos
